CurrentCareSource GeorgiaPolicy MP-MM-1411

Neonatal Discharge Criteria

Customize your policy alerts

Sign up for CareSource Georgia Policy MP-MM-1411 alerts

Get alerted when Policy MP-MM-1411 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines clinical criteria for medically appropriate discharge of neonates (non-technology-dependent and technology-dependent) from the neonatal unit; intended for providers managing NICU discharge planning for CareSource Georgia members.

Policy Summary

PayerCareSource Georgia

PolicyNeonatal Discharge Criteria

Policy CodePolicy MP-MM-1411

Change TypeNo material change

Effective DateMar 1, 2026

Last ReviewDec 17, 2025

Next Review DateMar 1, 2026

Key ActionDocument evidence of thermoregulation, cardio-respiratory stability, adequate oral feeding and weight gain, acceptable bilirubin levels, and completed home support and family teaching for technology-dependent infants prior to discharge.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2distinct criteria groups

48 hrsstable temperature observation

5–7 daysapnea/bradycardia observation

≤0.5 LPMmax home LFNC

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentCareSource GeorgiaPolicy MP-MM-1411

Neonatal Discharge Criteria

Customize your policy alerts

Sign up for CareSource Georgia Policy MP-MM-1411 alerts

Get alerted when Policy MP-MM-1411 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerCareSource Georgia

PolicyNeonatal Discharge Criteria

Policy CodePolicy MP-MM-1411

Change TypeNo material change

Effective DateMar 1, 2026

Last ReviewDec 17, 2025

Next Review DateMar 1, 2026

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2distinct criteria groups

48 hrsstable temperature observation

5–7 daysapnea/bradycardia observation

≤0.5 LPMmax home LFNC

Neonatal Discharge Coverage Criteria

Non-technology-dependent infant discharge

Covered when ALL of the following are met:

Thermoregulation Stability: Infant demonstrates ability to maintain normal body temperature while clothed in an open crib; up to 48 hours of stable body temperature is typically adequate for infants born < 37 weeks gestation; 12 hours stable for infants born ≥ 37 weeks; infants placed in an isolette solely for phototherapy do not require additional observation once phototherapy is completed.

Cardio-Respiratory Stability: Infant is stable on room air after discontinuation of oxygen therapy for up to 48 hours; if previously on caffeine, observed for apnea for 5 days off caffeine; no clinically significant bradycardia/desaturation (requires stimulation) or apnea for 5–7 days; no self-resolved bradycardia/desaturation events in the last 48 hours; isolated feeding-associated bradycardia should not delay discharge; infant passed car seat test if applicable.

Feeding and Adequate Weight Gain: Infant demonstrates adequate PO feeding by bottle or breast for up to 48 hours and overall weight gain is appropriate for gestational age and day of life.

Bilirubin: Acceptable bilirubin level per hours of life using the AAP Bilitool; consider risk factors including gestational age < 38 weeks, albumin < 3.0 g/dL, isoimmune hemolytic disease/G6PD/other hemolysis, sepsis, or significant clinical instability in the prior 24 hours.

Technology-dependent infant discharge

Covered when ALL of the following are met:

Cardio-Respiratory Stability: Infant is stable but may have ongoing technology needs such as: bronchopulmonary dysplasia (BPD) on low-flow nasal cannula at any FIO2 with flow rate ≤ 0.5 LPM; tracheostomy requiring positive pressure ventilation with stable ventilator settings and fraction of inspired O2 < 40% on a home ventilator.

Feeding and Adequate Weight Gain / Home Support: Infant may be gastrostomy or nasogastric tube dependent for feeds; appropriate home health care and family teaching must be completed prior to discharge.

This policy does not list any explicit exclusions or state‑specific limitations; State‑Specific Information and Conditions of Coverage are both marked NA in the policy document, and no related exclusions are provided.

Review and revision history is documented in the policy (dates of issue and updates), but there are no additional state‑level restrictions or special coverage caveats included in those sections.

Observation Periods, Device Thresholds, and Definitions

Observation periods and device thresholds

Thermoregulation observation windowInfant demonstrates ability to maintain normal body temperature while clothed in an open crib: up to 48 hours stable for infants born < 37 weeks; 12 hours stable for infants born ≥ 37 weeks; isolette used only for phototherapy does not require additional observation once phototherapy completed.

Cardio‑respiratory event‑free observationNo clinically significant bradycardia/desaturation (B/D) or apnea for 5–7 days; no self‑resolved B/D events in the last 48 hours; if previously on caffeine, observed for apnea for 5 days off caffeine.

Room air observation after oxygenInfant stable on room air after discontinuation of oxygen therapy for up to 48 hours.

Home oxygen / BPD thresholdBronchopulmonary dysplasia (BPD) infants may be discharged on low‑flow nasal cannula at any FiO2 with a flow rate ≤ 0.5 LPM.

Home ventilator thresholdInfant with tracheostomy requiring positive pressure ventilation may be discharged if ventilator settings are stable and FiO2 < 40% using a home ventilator.

Acceptable Bilirubin Level (per AAP/Bilitool)

Acceptable bilirubin referenceAcceptable bilirubin level determined based on hours of life per American Academy of Pediatrics (AAP) Bilitool (Bilitool.org).

Bilirubin risk factors to considerConsider gestational age < 38 weeks, albumin < 3.0 g/dL, isoimmune hemolytic disease/G6PD/other hemolysis, sepsis, or significant clinical instability in prior 24 hours.

Test typeBilirubin measured by blood test to assess neonatal hyperbilirubinemia and liver function per AAP guidance.

Car Seat Test Eligibility

Primary eligibilityInfant required to demonstrate cardio‑respiratory stability, including no clinically significant bradycardia/desaturation or apnea for 5–7 days and passing the car seat test if applicable.

Gestational age and riskCar seat test typically performed for infants born < 37 weeks gestation or those at risk for respiratory compromise.

Contextual criteriaEligibility for car seat tolerance testing is determined within the broader discharge criteria; isolated feeding‑associated bradycardia should not delay testing or discharge.

Stable Body Temperature (definition)

DefinitionStable body temperature: ability to maintain body temperature > 36.4° C axillary while clothed in an open bed/crib.

Observation implicationThermoregulation stability observation windows: up to 48 hours for infants born < 37 weeks and 12 hours for infants born ≥ 37 weeks as evidence of thermoregulation.

Isolette noteUse of an isolette solely for phototherapy does not require additional thermoregulation observation once phototherapy is completed.

Provider Requirements and Operational Notes

Prior Authorization

No prior authorization or billing codes specified

This policy contains no prior authorization requirements or listed billing codes for neonatal discharge. Appropriateness for discharge is determined by meeting the clinical stability and, for technology-dependent infants, home support requirements in the criteria sections.

Step Therapy

No step therapy required

The policy does not specify any step therapy or treatment sequencing requirements for neonatal discharge.

Documentation Required

Required clinical documentation for discharge

Document objective evidence that the infant meets the clinical stability criteria before discharge.

Thermoregulation: record stable body temperature >36.4°C axillary for the stated observation period (up to 48 hours for infants born <37 weeks; 12 hours for infants born ≥37 weeks). [[DO NOT include chunk refs in clinical text]]
Cardio-respiratory stability: record time off supplemental oxygen (up to 48 hours), observation off caffeine for 5 days if applicable, and event-free observation for 5–7 days for clinically significant apnea/bradycardia; note no self-resolved B/D events in the last 48 hours and car seat test result if applicable.
Feeding and weight: document adequate PO feeding by bottle or breast for up to 48 hours and expected weight gain for gestational age and day of life.
Bilirubin: document acceptable bilirubin level per AAP Bilitool and note relevant risk factors (e.g., gestational age <38 weeks, albumin <3.0 g/dL, hemolytic conditions, sepsis, recent clinical instability).
For technology-dependent infants: document stable ventilator settings with FiO2 <40% for home ventilator users or BPD low-flow NC settings (≤0.5 LPM), and completion of home health arrangements and family teaching for gastrostomy/NG tube feeding or tracheostomy care.

Denial Risk

Denial risk for failure to meet clinical stability or home support criteria

Discharge may be denied if the infant fails to meet any of the listed clinical stability criteria, including thermoregulation, cardio-respiratory stability, feeding/weight gain, acceptable bilirubin, or required home support/stable device settings for technology-dependent infants.

Thermoregulation not achieved within stated observation windows (48 hours for <37 weeks; 12 hours for ≥37 weeks).
Ongoing need for supplemental oxygen or insufficient observation off oxygen/caffeine (not observed 5 days off caffeine or insufficient 5–7 day event-free window).
Clinically significant bradycardia/desaturation or apnea events within the required observation periods (including self-resolved events in past 48 hours).
Inadequate PO feeding or failure to demonstrate expected weight gain.
Unacceptable bilirubin level per AAP Bilitool or presence of listed risk factors without appropriate management.
For technology-dependent infants: unstable ventilator settings/FiO2 ≥40% or inability to complete home health/family teaching for gastrostomy/NG/tracheostomy care.

Background and Rationale

Infants discharged from a neonatal admission remain at increased risk for morbidity and mortality; therefore, the policy emphasizes that discharge planning should begin at NICU admission to reduce delays and support a safe transition home. The focus of discharge readiness is on physiologic competencies — thermoregulation, feeding, respiratory control, and overall stability — rather than solely on weight or corrected gestational age.

Providers should ensure early multidisciplinary planning so required observations (for example thermoregulation and cardio‑respiratory stability) and education (feeding, car seat testing, home support when needed) are completed before discharge to mitigate post‑discharge risks.

Neonatal Discharge Criteria

Sign up for CareSource Georgia Policy MP-MM-1411 alerts

Neonatal Discharge Criteria

Sign up for CareSource Georgia Policy MP-MM-1411 alerts

Neonatal Discharge Coverage Criteria

Observation Periods, Device Thresholds, and Definitions

Provider Requirements and Operational Notes

Background and Rationale

Policy Dates and Revision History